Dr. Carolyn Hoppe
Senior Medical Director, Clinical Lead
Global Blood Therapeutics (PFIZER)
Dr. Carolyn Hoppe is Senior Medical Director and Clinical Lead for the Inclacumab THRIVE studies at Global Blood Therapeutics. Carolyn is also a hematologist by training and prior to joining GBT, she enjoyed a 20-year career as Professor of Pediatrics in Hematology-Oncology at University of California San Francisco (UCSF) Benioff Children’s Hospital in Oakland. She is excited to share her clinical experience and expertise in sickle cell disease and contribute to the development of new therapies for SCD.
